|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181.40 CHF | +1.51% |
|
-0.87% | +41.17% |
| 24/06 | Tecan Group Partners with Nvidia to Add Agentic AI Capability in Lab Analytics Platform | MT |
| 26/05 | Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.89 | 4.49 | 4.05 | 2.08 | 1.47 | |||||
Return on Total Capital | 7.92 | 5.76 | 5.09 | 2.55 | 1.8 | |||||
Return On Equity % | 12.42 | 9.38 | 9.76 | 4.86 | -8.56 | |||||
Return on Common Equity | 12.42 | 9.38 | 9.76 | 4.86 | -8.56 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.16 | 38.28 | 36.34 | 34.32 | 35.22 | |||||
SG&A Margin | 20.3 | 18.74 | 17.87 | 19.69 | 22.7 | |||||
EBITDA Margin % | 19.39 | 16.41 | 16.76 | 11.68 | 9.16 | |||||
EBITA Margin % | 18.06 | 14.96 | 14.44 | 9.53 | 7.11 | |||||
EBIT Margin % | 15.46 | 12.91 | 12.62 | 7.46 | 5.1 | |||||
Income From Continuing Operations Margin % | 12.85 | 10.59 | 12.29 | 7.24 | -12.54 | |||||
Net Income Margin % | 12.85 | 10.59 | 12.29 | 7.24 | -12.54 | |||||
Net Avail. For Common Margin % | 12.85 | 10.59 | 12.29 | 7.24 | -12.54 | |||||
Normalized Net Income Margin | 9.17 | 7.78 | 7.78 | 4.88 | 2.98 | |||||
Levered Free Cash Flow Margin | 8.3 | 7.31 | 11.61 | 10.83 | 12.86 | |||||
Unlevered Free Cash Flow Margin | 8.57 | 7.38 | 11.67 | 11.01 | 13.06 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.56 | 0.51 | 0.45 | 0.46 | |||||
Fixed Assets Turnover | 8.25 | 7.64 | 7.29 | 6.39 | 6.3 | |||||
Receivables Turnover (Average Receivables) | 6.87 | 6.85 | 5.71 | 4.94 | 5.28 | |||||
Inventory Turnover (Average Inventory) | 2.63 | 2.57 | 2.46 | 2.53 | 2.58 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.19 | 2.39 | 2.86 | 1.61 | 2.46 | |||||
Quick Ratio | 1.34 | 1.45 | 1.96 | 1.15 | 1.69 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.38 | 0.54 | 0.28 | 0.48 | |||||
Days Sales Outstanding (Average Receivables) | 53.12 | 53.32 | 63.92 | 74.06 | 69.13 | |||||
Days Outstanding Inventory (Average Inventory) | 138.58 | 142.06 | 148.09 | 144.59 | 141.45 | |||||
Average Days Payable Outstanding | 11.46 | 14.89 | 21.03 | 22.59 | 20.25 | |||||
Cash Conversion Cycle (Average Days) | 180.24 | 180.49 | 190.97 | 196.05 | 190.33 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 25.61 | 22.66 | 23.48 | 22.39 | 18.96 | |||||
Total Debt / Total Capital | 20.39 | 18.47 | 19.01 | 18.29 | 15.94 | |||||
LT Debt/Equity | 24.54 | 21.61 | 22.53 | 4.18 | 18.06 | |||||
Long-Term Debt / Total Capital | 19.54 | 17.62 | 18.24 | 3.41 | 15.18 | |||||
Total Liabilities / Total Assets | 38.64 | 35.84 | 34.96 | 32.34 | 32.19 | |||||
EBIT / Interest Expense | 35.62 | 112.3 | 139.09 | 27.09 | 15.68 | |||||
EBITDA / Interest Expense | 47.66 | 154.07 | 199.27 | 47.66 | 32.46 | |||||
(EBITDA - Capex) / Interest Expense | 41.06 | 136.53 | 179.34 | 41.73 | 27.21 | |||||
Total Debt / EBITDA | 1.6 | 1.52 | 1.63 | 2.62 | 2.35 | |||||
Net Debt / EBITDA | 0.37 | 0.08 | -0.26 | -0.69 | -1 | |||||
Total Debt / (EBITDA - Capex) | 1.86 | 1.71 | 1.81 | 2.99 | 2.8 | |||||
Net Debt / (EBITDA - Capex) | 0.43 | 0.09 | -0.28 | -0.79 | -1.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.52 | 20.88 | -6.11 | -13.04 | -5.54 | |||||
Gross Profit, 1 Yr. Growth % | 15.22 | 7.22 | -10.87 | -17.89 | -3.04 | |||||
EBITDA, 1 Yr. Growth % | 36.13 | 2.26 | -4.06 | -37.86 | -29.54 | |||||
EBITA, 1 Yr. Growth % | 36.59 | 0.12 | -9.35 | -40.96 | -33.66 | |||||
EBIT, 1 Yr. Growth % | 21.47 | 0.91 | -8.17 | -46.86 | -40.28 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 17.34 | -0.44 | 9.04 | -48.77 | -263.53 | |||||
Net Income, 1 Yr. Growth % | 17.34 | -0.44 | 9.04 | -48.77 | -263.53 | |||||
Normalized Net Income, 1 Yr. Growth % | 18.19 | 2.79 | -6.09 | -43.56 | -46.5 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 14.62 | -4.15 | 8.76 | -48.64 | -265.2 | |||||
Accounts Receivable, 1 Yr. Growth % | 23.39 | 19.66 | 6.62 | -5.28 | -18.25 | |||||
Inventory, 1 Yr. Growth % | 56.23 | 20.66 | -15.38 | -9.38 | -7.78 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 89.76 | -0.62 | -2.84 | 1.49 | -9.87 | |||||
Total Assets, 1 Yr. Growth % | 80.06 | 6.01 | -1.99 | 2.29 | -19.96 | |||||
Tangible Book Value, 1 Yr. Growth % | -77.5 | 115 | 36.86 | 9.61 | -6.7 | |||||
Common Equity, 1 Yr. Growth % | 66.96 | 10.84 | -0.65 | 6.41 | -19.78 | |||||
Cash From Operations, 1 Yr. Growth % | -18.47 | -24.48 | 25.18 | -7.49 | -7.11 | |||||
Capital Expenditures, 1 Yr. Growth % | 14.17 | -14.98 | -15.77 | -21.38 | -1.47 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -45.49 | 6.52 | 49.13 | -17.44 | 8.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -43.94 | 4.16 | 48.4 | -16.55 | 8.43 | |||||
Dividend Per Share, 1 Yr. Growth % | 21.74 | 3.57 | 3.45 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.92 | 25.12 | 6.53 | -9.64 | -9.37 | |||||
Gross Profit, 2 Yr. CAGR % | 17.29 | 11.15 | -2.24 | -14.45 | -10.78 | |||||
EBITDA, 2 Yr. CAGR % | 33.37 | 17.99 | -0.95 | -23.74 | -32.15 | |||||
EBITA, 2 Yr. CAGR % | 34.72 | 16.94 | -4.73 | -27.89 | -35.48 | |||||
EBIT, 2 Yr. CAGR % | 27.92 | 10.72 | -3.74 | -31.29 | -41.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.95 | 8.08 | 4.19 | -25.26 | -8.47 | |||||
Net Income, 2 Yr. CAGR % | 28.95 | 8.08 | 4.19 | -25.26 | -8.47 | |||||
Normalized Net Income, 2 Yr. CAGR % | 28.72 | 10.14 | -1.75 | -28.41 | -42.98 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 26.95 | 4.81 | 2.1 | -25.26 | -7.89 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.7 | 21.51 | 12.95 | 0.49 | -12 | |||||
Inventory, 2 Yr. CAGR % | 28.04 | 37.3 | 1.05 | -12.43 | -8.58 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 43.68 | 37.33 | -1.73 | -0.7 | -4.36 | |||||
Total Assets, 2 Yr. CAGR % | 45.74 | 38.16 | 1.93 | 0.13 | -9.51 | |||||
Tangible Book Value, 2 Yr. CAGR % | -48.33 | -30.45 | 71.54 | 22.48 | 1.12 | |||||
Common Equity, 2 Yr. CAGR % | 36.33 | 36.04 | 4.94 | 2.82 | -7.61 | |||||
Cash From Operations, 2 Yr. CAGR % | 31.11 | -21.53 | -2.77 | 7.61 | -7.3 | |||||
Capital Expenditures, 2 Yr. CAGR % | 69.84 | -1.48 | -15.38 | -18.62 | -11.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 15.42 | -23.8 | 26.04 | 10 | -3.79 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 16.67 | -23.59 | 24.33 | 10.33 | -3.27 | |||||
Dividend Per Share, 2 Yr. CAGR % | 12.82 | 12.29 | 3.51 | 1.71 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 16.82 | 21.57 | 13.7 | -0.44 | -8.3 | |||||
Gross Profit, 3 Yr. CAGR % | 13.69 | 13.83 | 3.26 | -7.76 | -10.81 | |||||
EBITDA, 3 Yr. CAGR % | 22.89 | 22.07 | 10.12 | -15.91 | -24.48 | |||||
EBITA, 3 Yr. CAGR % | 23.29 | 22.03 | 7.42 | -19.56 | -28.43 | |||||
EBIT, 3 Yr. CAGR % | 18.74 | 18.19 | 4.02 | -21.9 | -32.72 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 19.83 | 18.3 | 8.4 | -17.76 | -2.97 | |||||
Net Income, 3 Yr. CAGR % | 19.83 | 18.3 | 8.4 | -17.76 | -2.97 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.94 | 19.36 | 4.44 | -19.24 | -33.41 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 18.35 | 15.6 | 6.12 | -18.8 | -2.64 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.17 | 14.29 | 16.33 | 6.51 | -6.19 | |||||
Inventory, 3 Yr. CAGR % | 13.21 | 25.53 | 16.84 | -2.56 | -10.91 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 81.72 | 27.07 | 22.37 | -0.67 | -3.85 | |||||
Total Assets, 3 Yr. CAGR % | 32.52 | 31.07 | 23.22 | 2.05 | -7.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | -33.84 | -16.89 | -12.85 | 47.75 | 11.86 | |||||
Common Equity, 3 Yr. CAGR % | 25.99 | 27.24 | 22.51 | 5.43 | -5.34 | |||||
Cash From Operations, 3 Yr. CAGR % | 22.37 | 9.09 | -8.31 | -4.37 | 2.46 | |||||
Capital Expenditures, 3 Yr. CAGR % | 31.99 | 34.85 | -6.49 | -17.42 | -13.26 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 4.81 | 12.37 | -4.69 | 8.83 | 10.71 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.81 | 12.34 | -4.66 | 8.23 | 10.92 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.06 | 9.65 | 9.26 | 2.33 | 1.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.34 | 15.84 | 12.59 | 7.97 | 3.84 | |||||
Gross Profit, 5 Yr. CAGR % | 11.29 | 10.6 | 7.03 | 1.54 | -2.6 | |||||
EBITDA, 5 Yr. CAGR % | 18.81 | 15.26 | 12.73 | 1.13 | -9.72 | |||||
EBITA, 5 Yr. CAGR % | 19.28 | 14.94 | 11.21 | -1.13 | -12.9 | |||||
EBIT, 5 Yr. CAGR % | 16.34 | 12.55 | 9.18 | -4.86 | -17.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 17.4 | 12.94 | 13.31 | -1.55 | 1.31 | |||||
Net Income, 5 Yr. CAGR % | 17.4 | 12.94 | 13.31 | -1.55 | 1.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.97 | 11.91 | 10.15 | -2.71 | -18.57 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.22 | 11.12 | 11.56 | -2.9 | 0.27 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.42 | 10.08 | 12.48 | 8.56 | 4.04 | |||||
Inventory, 5 Yr. CAGR % | 8.14 | 13.41 | 8.18 | 8.69 | 5.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 49.26 | 47.65 | 42.1 | 15.13 | 10.88 | |||||
Total Assets, 5 Yr. CAGR % | 22.08 | 21.36 | 19.32 | 17.69 | 8.9 | |||||
Tangible Book Value, 5 Yr. CAGR % | -18.58 | -8.11 | -3.15 | -2.95 | -7.51 | |||||
Common Equity, 5 Yr. CAGR % | 20.25 | 19.8 | 17.11 | 16.84 | 9.43 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.41 | 5.23 | 11.61 | 8.5 | -7.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | 31.97 | 23.16 | 10.49 | 10.19 | -8.73 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.62 | 3.23 | 12.83 | 11.42 | -4.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.22 | 3.35 | 12.86 | 11.53 | -4.44 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.86 | 7.71 | 7.39 | 6.4 | 5.46 |
- Stock Market
- Stocks
- TECN Stock
- Financials Tecan Group AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















